Zeeshan Mansuri, MD

Department of Psychiatry, Yale New Haven School of Medicine, New Haven, Connecticut

  • 34Articles
  • 445.1KReads1
  • 2019–2026Active
  • 90Collaborators
  • 89Citations2

About

Zeeshan Mansuri, MD, is affiliated with the Department of Psychiatry at Yale New Haven School of Medicine. Between 2019 and 2026, Mansuri has authored 34 articles focusing on diverse psychiatric topics including COVID, child and adolescent psychiatry, addiction, schizophrenia and schizoaffective disorders, autism spectrum disorders, depression, and women's mental health. Mansuri’s work covers subjects such as biomarkers in neuropsychiatric disorders, gender-affirming surgeries, psychotropic drug interactions, and treatment modalities like ketamine and repetitive transcranial magnetic stimulation. Frequent collaborators include Chintan Trivedi, Shailesh Jain, and Kaushal Shah.

Publications

PCC
MiRNAs as Biomarkers in Neuropsychiatric Disorders
Narrative Review

MiRNAs as Biomarkers in Neuropsychiatric Disorders

April 30, 2026

This review highlights how microRNA dysregulation can shed light on the molecular mechanisms underlying neuropsychiatric disorders and serve as potential biomarkers for early diagnosis and prognosis.
, , , et al
PCC
Gender-Affirming Surgery, Gender Dysphoria, and QOL
Review Article

Gender-Affirming Surgery, Gender Dysphoria, and QOL

November 11, 2025

Those who receive gender dysphoria treatment at a younger age may experience lower rates of suicidal ideation, underscoring potential mental health benefits of timely intervention.
, , , et al
PCC
Role of GLP-1 Receptor Agonists in AUD
Narrative Review

Role of GLP-1 Receptor Agonists in AUD

May 15, 2025

The authors examine the potential benefits, dosages, and mechanisms of GLP-1 receptor agonists on alcohol consumption and how they can potentially modify alcohol-seeking behavior.
, , , et al
PCC
Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome
Original Research

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

November 7, 2024

PCOS symptoms extend beyond reproductive issues, with noted correlations to anxiety, depression, and suicidal attempts. This study assessed psychiatric comorbidities among hospitalized adolescent females with PCOS.
, , , et al
PCC
Camptocormia and Antipsychotic Medications
Brief Report

Camptocormia and Antipsychotic Medications

May 23, 2024

Camptocormia, or “bent spine syndrome,” is an often-overlooked adverse effect of antipsychotics; early diagnosis and treatment is essential to prevent severe consequences.
, , , et al
PCC
Drug Interactions Between Psychotropic Medications and Mpox Treatment
Letter to the Editor

Drug Interactions Between Psychotropic Medications and Mpox Treatment

February 15, 2024

The authors review pharmacologic interactions of Mpox treatments with psychotropic medications and antidepressants, antipsychotics, mood stabilizers, and sedatives.
, , , et al
PCC
Intravenous Ketamine vs Intranasal Esketamine for TRD
Letter to the Editor

Intravenous Ketamine vs Intranasal Esketamine for TRD

February 13, 2024

Dr Mansuri and colleagues compare the pros and cons of IV ketamine and intranasal esketamine for treatment-resistant depression.
, , , et al
PCC
Psychiatric Disorders Among Child Welfare Custody Patients
Original Research

Psychiatric Disorders Among Child Welfare Custody Patients

November 21, 2023

Children and adolescents in the child welfare system are associated with a higher risk of mental health problems. Factors that can prevent psychiatric comorbidities in the child welfare population...
, , , et al
PCC
Psychiatric Comorbidities of Neurofibromatosis
Original Research

Psychiatric Comorbidities of Neurofibromatosis

October 3, 2023

Neurofibromatosis is a group of inherited neurocutaneous disorders that includes neurofibromatosis types 1 and 2 and schwannomatosis. This study assessed the prevalence of psychiatric comorbidities in patients with neurofibromatosis.
, , , et al
PCC
rTMS in Depression, Schizophrenia, and OCD
Meta-Analysis

rTMS in Depression, Schizophrenia, and OCD

September 26, 2023

In treatment-resistant depression, repetitive transcranial magnetic stimulation had higher odds of response and remission rates compared to sham.
, , , et al
PCC
Elevated Creatine Phosphokinase and Antipsychotics
Case Report

Elevated Creatine Phosphokinase and Antipsychotics

September 21, 2023

Elevated creatine phosphokinase should not be presumed to be neuroleptic malignant syndrome in patients taking antipsychotics.
, , , et al
PCC
Olanzapine-Induced Bradycardia
Case Report

Olanzapine-Induced Bradycardia

August 15, 2023

A 34-year-old man with history of MDD developed significant bradycardia with olanzapine use.
, , , et al

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe